SightfileU.S. market data from official filings
Companies › LNTH
LANTHEUS HLDGS INC (LNTH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001521036 · EDGAR filings · Updated 2026-06-03
LANTHEUS HLDGS INC (LNTH) has reported institutional ownership of 109.6%, with 402 institutional managers holding positions valued at $5.41B per the latest 13F reporting period.
Institutional ownership
109.6%
Institutional managers
402
Reported 13F value
$5.41B
Insider activity
56 trans.
−$389.8M net selling
Latest updates
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-06-03 — Insider transaction reported (Form 4)
- 2026-05-29 — SD filed
- 2026-05-18 — Insider transaction reported (Form 4)
- 2026-05-18 — Insider transaction reported (Form 4)
- 2026-05-18 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, LANTHEUS HLDGS INC has 402 institutional holders and institutional ownership of 109.6%.
Insider activity
Insiders reported 56 transactions (0 buys, 14 sells) across 20 reporting insiders, with a net reported value of −$389.8M.
Related companies
CELCUITY INC (CELC) · MSA SAFETY INC (MSA) · BIO RAD LABS INC (BIO) · AVANTOR INC (AVTR) · DIANTHUS THERAPEUTICS INC (DNTH) · QIAGEN NV (QGEN)
See full history, cross-references and alerts on SightfileSightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-03.